Biotech valuations and funding availability went into reverse in the second half of 2021, following a period of abundant financing. Meanwhile, big pharma companies face their own problems, with many b
SEOUL – Following a green light from the U.S. FDA to begin an international Phase III clinical trial with its novel liver cancer therapy, SillaJen Inc. said preparations for the study are proceedi
In Vitro Diagnostics Acquisitions Siemens AG Siemens Medical Solutions USA, Inc. Diagnostic Products Corp. Siemens has acquired Diagnostic Products (immunodiagnostics) for $1.86bn. DP shareholders